Returning to ASH, focused on Hemophilia A. Our new results demonstrate nonviral, targeted payload delivery to liver with our RIPPLE™ ultrasound mediated delivery technology resulting in up to 65% of normal Factor VIII protein expression in NHP models: sonothera.com/press-releas...
#ASH25 #SonoThera

New data at ASN Kidney Week 2025 demonstrating the potential of ultrasound-mediated delivery. Learn about our latest results in the treatment of X-Linked Alport Syndrome, delivering full-length gene expression: sonothera.com/press-releas...

#KidneyWk #SonoThera #XLAS #ultrasound #geneticmedicine

SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy - www.businesswire.com/news/home/20...

Excited for @ASGCTHERAPY, showcasing our latest data demonstrating the promise of ultrasound-mediated delivery (UMD) for Duchenne Muscular Dystrophy and Hemophilia A, and UMD’s potential to address critical hurdles in genetic medicine. Learn more: sonothera.com/wp-content/u...
#ASGCT2025

Presenting new data @MDAorg Clinical & Scientific Conference highlighting potential of genetic medicine using targeted, ultrasound-mediated delivery in treating DMD. Learn more: sonothera.com/press-releases #geneticmedicine #ultrasound #ultrasoundmediated #SonoThera #MDAconference #MuscularDystrophy

We're starting December at #ASH24 unveiling our newest data showcasing the potential of nonviral targeted, ultrasound-mediated gene delivery to the liver. Learn more: sonothera.com/press-releas...
#genetherapy #microbubble #ultrasound #nonviral #sonoporation #hemophilia #liver